TIMPs Expression as A Maternal Cell Free Plasma Biomarker of Severe Preeclampsia: A Case-Control Study

Objective: Preeclampsia (PE) is a pregnancy related disorder with prevalence of 6-7%. Insufficient trophoblasticinvasion leads to incomplete remodeling of spiral arteries and consequent decrease in feto-placental perfusion. Alteredplacental expression of tissue inhibitors of matrix metalloproteinase (TIMPs) is considered to be involved in this processwhile the balance between matrix metalloproteinases (MMPs) and TIMPs contributes to remodeling of the placentaand uterine arteries by degradation and refurbishing of extracellular matrix (ECM). Therefore, TIMPs, fetal expressionpattern was evaluated with the aim of its potential to be used as a determinant for the (early) detection of PE. Materials and Methods: In this case-control study, cell free fetal RNA (cffRNA) released by placenta into the maternalblood was used to determine expression patterns of TIMP1, 2, 3 and 4 in the severe preeclamptic women in comparisonwith the normal pregnant women. Whole blood from 20 preeclamptic and 20 normal pregnant women in their 28-32weeks of gestational age was collected. The second control group consisted of 20 normal pregnant women in either 14or 28 weeks of gestation (each 10). cffRNA was extracted from plasma and real-time polymerase chain reaction (PCR)was done to determine the expression levels of TIMP1, 2, 3 and 4 genes. Results: Statistical analysis of the results showed significant higher expression of TIMP1-4 in the preeclamptic womenin comparison with the control group (P=0.029, 0.037, 0.037 and 0.049, respectively). Also, an increased level of TIMPsexpression was observed by comparing 14 to 28 weeks of gestational age in the normal pregnant women in the secondcontrol group. Conclusion: An increased cffRNA expression level of TIMPs may be correlated with the intensity of placental vasculardefect and may be used as a determinant of complicated pregnancies with severe preeclampsia